Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Equity Ratio (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Equity Ratio data on record, last reported at 0.85 in Q4 2025.

  • For Q4 2025, Equity Ratio fell 1.61% year-over-year to 0.85; the TTM value through Dec 2025 reached 0.85, down 1.61%, while the annual FY2025 figure was 0.85, 1.61% down from the prior year.
  • Equity Ratio reached 0.85 in Q4 2025 per PLSE's latest filing, roughly flat from 0.85 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.89 in Q1 2025 and bottomed at 0.15 in Q1 2023.
  • Average Equity Ratio over 5 years is 0.62, with a median of 0.75 recorded in 2021.
  • The widest YoY moves for Equity Ratio: up 2697.89% in 2023, down 128.88% in 2023.
  • A 5-year view of Equity Ratio shows it stood at 0.75 in 2021, then tumbled by 103.85% to 0.03 in 2022, then soared by 2697.89% to 0.75 in 2023, then grew by 15.63% to 0.87 in 2024, then decreased by 1.61% to 0.85 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.85 in Q4 2025, 0.85 in Q3 2025, and 0.87 in Q2 2025.